Cystatin M/E expression in inflammatory and neoplastic skin disorders

British Journal of Dermatology

Volumn 147, Issue 1, 2002, Pages 87-94

  Zeeuwen, P L J M ^a   Van Vlijmen Willems, I M J J ^a   Egami, H ^b   Schalkwijk, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cysteine proteinases; Host defence; Skin tumours; Wound healing

Indexed keywords

CYSTATIN; CYSTATIN E; CYSTATIN M; CYSTEINE PROTEINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ARTICLE; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KERATOACANTHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; SKIN BIOPSY; SKIN INFLAMMATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; WOUND HEALING;

CARCINOMA, SQUAMOUS CELL; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; DERMATITIS, ATOPIC; HUMANS; PSORIASIS; SKIN; SKIN DISEASES; SKIN NEOPLASMS; SWEAT; WOUND HEALING;

EID: 0036064858     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04785.x     Document Type: Article

References (29)

1. Cystatins
2. Cystatins in health and disease
3. Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression
4. Proteinase inhibition, immunoglobulin-binding proteins and a novel antimicrobial principle
5. Viral therapy: Prospects for protease inhibitors
6. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: A new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase
7. Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization
8. Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2
9. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins
10. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer
11. Expression of SKALP/elafin during wound healing in human skin
12. Cysteine proteinase inhibitor in eccrine sweat is derived from sweat gland
13. Proteolytic enzymes in human eccrine sweat: A screening study
14. Partial purification and characterization of cysteine proteinases in eccrine sweat
15. In situ detection of cytokine messenger RNAs in the eccrine sweat gland of normal human skin
16. Cytokine-inducing activity of family 2 cystatins
17. Cystatins - Inhibitors of cysteine proteinases
18. Expression of keratinocyte transglutamine mRNA revealed by in situ hybridization
19. Antibacterial activity of antileukoprotease
20. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes
21. Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature
22. The trappin gene family proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core
23. Skin-derived antileucoproteases (SKALPs): Characterization of two new elastase inhibitors from psoriatic epidermis
24. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia
25. Antileukoprotease in human skin: An antibiotic peptide constitutively produced by keratinocytes
26. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens
27. Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis
28. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor
29. Cathepsin B and cystatins: Evidence for a role in cancer progression